MONTRÉAL, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company” or “Premier Health”), a leading Canadian health tech company, today announced that its subsidiaries, Code Bleu, Placement Premier Soin, Premier Health Nordik and Solutions Nursing (the “Quebec Subsidiaries”), have been notified by the Autorité des marchés publics (AMP) of their registration in the Register of Enterprises Ineligible for Public Contracts under the Act respecting contracting by public bodies ( ...

Core Viewpoint - Oscar Health is positioned as a contrarian investment opportunity in the health insurance sector, demonstrating strong growth and profitability, particularly in light of potential regulatory changes that could expand its market significantly [1][15]. Company Overview and Q1 2025 Performance - Oscar Health is a tech-native health insurer focusing on individual and family plans through ACA exchanges, currently operating in 18 states and insuring approximately 2 million members, representing about 1 in every 13 ACA enrollees nationwide [4]. - In Q1 2025, Oscar reported $275.3 million in net income, a significant increase from $177.4 million a year prior, with total revenue reaching $3.05 billion, reflecting a robust 42% year-over-year growth [5]. - The company achieved a record-low SG&A ratio of 15.8%, down from 18.4%, indicating improved operational efficiency under new leadership [6]. Market Opportunity Analysis - The introduction of the Choose Medicare Act proposes a Medicare Part E public option, which could significantly increase Oscar's addressable market, potentially tripling it if the legislation passes [10]. - Oscar's digital infrastructure and technology position it well to capitalize on the expected influx of consumers seeking coverage through public marketplaces [10]. Valuation Discussion - Oscar trades at 14 times projected 2027 earnings, which is considered a bargain given its high double-digit revenue growth [11]. - The company's market cap of $4.8 billion is less than 50% of its current annual revenue, suggesting a valuation disconnect compared to traditional insurers [11]. Investment Considerations - The risk-reward profile favors buyers, with the potential for Oscar's valuation to increase significantly if the public option is realized, transforming it from a $5 billion to a $15 billion company within 18 months [13]. - Even without the Medicare Part E, Oscar's compelling growth metrics and operational improvements make it an attractive investment opportunity [13][15]. - The market currently undervalues Oscar as a traditional insurer, while it operates as a technology company in the insurance space, creating a unique investment opportunity [14].